When Ottawa’s Fullscript first opened its doors in 2011, its founders had a simple yet ambitious vision: to bridge the gap between clinicians and patients by seamlessly integrating evidence-based supplement prescribing, advanced lab testing and adherence tools into everyday practice. Fast-forward to 2025, and that vision has drawn renewed backing from HGGC, Snapdragon Capital Partners and Leonard Green & Partners—an endorsement that bodes well for Canada’s burgeoning digital health sector.
A New Infusion of Confidence
The announcement landed in mid-May: HGGC and Snapdragon deepening their stakes in Fullscript, supported by a continuation vehicle led by Leonard Green & Partners. For investors who first came aboard in 2021, the deal isn’t just a moment to celebrate returns—it’s a signal that Fullscript’s patient-centred model remains ahead of the pack. “This investment allows us to continue advancing our technology, expanding our services, and empowering more practitioners to deliver personalized, proactive care,” says Fullscript co-founder and CEO Kyle Braatz.
From Start-Up to Scale-Up
Fullscript’s growth story is one of measured ambition. From its early days helping boutique naturopathic clinics place supplement orders, the platform now supports more than 100,000 providers and 10 million patients across North America. Its lab’s network—integrated directly into clinic workflows—has transformed what once was a fragmented process of bloodwork orders, sample tracking and follow-up into a single, clinician-friendly interface.
Yet what sets Fullscript apart is its focus on long-term outcomes. Through its patient adherence app, individuals can track their supplement routines, receive gentle reminders and access educational content curated by their practitioners. The result? Higher adherence rates, better health outcomes, and a reinforcing cycle of trust between patient and provider.
Powering Preventive Health in Canada
In Canada, where wait times and rising healthcare costs dominate headlines, Fullscript’s preventive ethos strikes a compelling chord. Dietitians, chiropractors and integrative physicians alike are embracing the platform to prescribe targeted nutritional interventions that can help stave off chronic conditions—often before they require more intensive medical treatments. Fullscript’s Ottawa-based team has grown in tandem, with plans to expand its local customer-support centre and deepen partnerships with Canadian labs and distributors to cut delivery times even further.
Aligning Investors and Innovators
For HGGC—managing over US$8 billion in commitments—the renewed investment fits squarely within a portfolio that prizes technology-driven health and wellness companies. Snapdragon Capital Partners, whose consumer-focused growth strategy has driven successes in franchising and B2B2C services, likewise sees Fullscript as emblematic of next-generation care delivery. Leonard Green & Partners’ continuation vehicle offered a dual benefit: it allowed earlier backers to realize some liquidity, while infusing fresh growth capital and ensuring all stakeholders remained aligned on Fullscript’s trajectory.
“This transaction reflects our conviction in Fullscript’s long-term value creation potential,” explains Mark Grabowski, Founder and Managing Partner at Snapdragon. David Fox and Garrett Hall, co-heads of LGP’s Sage strategy, add that they look forward to supporting Fullscript’s evolution as a market leader with “strong competitive positions and sustainable growth.”
What Lies Ahead
Armed with this new round of financing, Fullscript has its sights set on several strategic priorities: enhancing its machine-learning capabilities to deliver ever-more tailored supplement recommendations; rolling out richer analytics dashboards for clinicians; and exploring opportunities to extend its preventive-care toolkit into adjacent markets.
For Canadian practitioners and their patients, the upside is clear: faster access to reliable lab services, deeper insights into treatment effectiveness and more engaging tools to keep health goals front and centre. And for Fullscript—a once-young disruptor now entering its teenage years—this fresh infusion of confidence may be the catalyst that propels whole-person care into the mainstream.
